Sudden Increases in U.S. Stimulant Prescribing: Alarming or Not?

J Atten Disord. 2023 Apr;27(6):571-574. doi: 10.1177/10870547231164155. Epub 2023 Mar 22.

Authors

Margaret H Sibley¹, Stephen V Faraone², Joel T Nigg³, Craig B H Surman⁴

Affiliations

¹ University of Washington School of Medicine, Seattle, USA.
² SUNY Upstate Medical University, Syracuse, USA.
³ Oregon Health and Science University, Portland, USA.
⁴ Harvard Medical School, Boston, MA, USA.

PMID: 36946184
DOI: 10.1177/10870547231164155

No abstract available

Publication types

Editorial

MeSH terms

Attention Deficit Disorder with Hyperactivity* / drug therapy
Attention Deficit Disorder with Hyperactivity* / epidemiology
Central Nervous System Stimulants* / adverse effects
Humans
Methylphenidate* / therapeutic use
Practice Patterns, Physicians'

Substances

Central Nervous System Stimulants
Methylphenidate